Published 2020
| Version v1
Publication
Why not consider an endothelin receptor antagonist against SARS‐CoV‐2?
Creators
Contributors
Others:
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/1008090
- URN
- urn:oai:iris.unige.it:11567/1008090
Origin repository
- Origin repository
- UNIGE